New Materials Series B Investors & VC Firms
469 firms in this list, with a median first check of $550K. 98 of them lead rounds. Generated from verified public data and updated continuously.
PGE Ventures
WarsawSeed–Late Stage$216K
1 person
Yuanta Investment
SeoulSeed–Late Stage$1M – $15M
Ameba Capital
ShanghaiSeed–Late Stage
3 people
NATO Innovation Fund
AmsterdamSeed–Series B$16.2M
3 people
SL Investment Ltd.
SeoulSeries A–Late Stage$500K – $2M
Chang'an Capital
BeijingSeed–Series B
3 people
Inspired Evolution Investment Management Pty Ltd.
Cape TownSeries A–Late Stage$1.5M – $15M
Murray Hill Group
New YorkSeed–Late Stage
3 people
TD Growth Capital Co. Ltd.
ShanghaiSeed–Series B
3 people
Treefrog Accelerator
Greater Toronto AreaSeed–Growth
3 people
Sorin Investments
MumbaiSeries A–Series B
1 person
BCP Ventures
DoverSeed–Series B
2 people
BSK Investment
SeoulSeed–Late Stage
2 people
Wild Basin Investments
TexasSeed–Growth
2 people
INCJ, Ltd.
TokyoSeed–Late Stage
1 person
City of Summerside Economic Development
SummersideSeed–Growth
2 people
Malaysia Debt Ventures Bhd.
Kuala LumpurSeed–Late Stage
2 people
Rio Tinto Ventures
Seed–Growth
2 people
Shenzhen Leaguer Tsing-Yuan Venture Capital Management Co., Ltd.
ShenzhenSeed–Series B
2 people
Trellis Capital Corporation
TorontoSeries A–Series B
2 people
Shanghai STVC Group
ShanghaiSeed–Late Stage
1 person
Carrier Ventures
Palm Beach GardensSeries A–Series B
Holcim MAQER Ventures
ZurichSeed–Growth
Sojitz
TokyoSeed–Growth
Related lists
Series B Investors & VC Firms (4254)Series B Investors & VC Firms in North America (2319)Series B Investors & VC Firms in United States (2067)SaaS Series B Investors & VC Firms (1448)Series B Investors & VC Firms in Europe (1431)Series B Investors & VC Firms in Asia-Pacific (1377)Series B Investors & VC Firms in Global (1330)Healthtech Series B Investors & VC Firms (1324)Enterprise Software Series B Investors & VC Firms (1310)AI & Machine Learning Series B Investors & VC Firms (1234)
Data sourced from public filings and firms' own websites — see our methodology.











